Angelica sinensis polysaccharide (ASP) attenuates diosbulbin-B (DB)-induced hepatotoxicity through activating the MEK/ERK pathway

References

• Ma Y, Niu C, Wang J, et al. Diosbulbin B-induced liver injury in mice and its mechanism. Hum Exp Toxicol. 2014;33(7): p. 729–36.
   PubMed Web of Science ®Google Scholar
• Jiang JZ, Yang BH, Ji LL, et al. Metabolic-induced cytotoxicity of diosbulbin B in CYP3A4-expressing cells. Toxicol In Vitro. 2017;38(p):59–66.
   PubMed Web of Science ®Google Scholar
• Yang R, Wei M, Yang F, et al. Diosbulbin B induced G(2)/M cell cycle arrest in hepatocytes by miRNA-186-3p and miRNA-378a-5p-mediated the decreased expression of CDK1. Toxicol Appl Pharmacol. 2018;357(p):1–9.
   PubMed Web of Science ®Google Scholar
• Li C, Li M, Xue Y. Downregulation of CircRNA CDR1as specifically triggered low-dose Diosbulbin-B induced gastric cancer cell death by regulating miR-7-5p/REGγ axis. Biomed Pharmacother. 2019;120(p):109462.
   PubMed Web of Science ®Google Scholar
• Li C, Qiu J, Xue Y. Low-dose Diosbulbin-B (DB) activates tumor-intrinsic PD-L1/NLRP3 signaling pathway mediated pyroptotic cell death to increase cisplatin-sensitivity in gastric cancer (GC). Cell Biosci. 2021;11(1): p. 38.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Miao H, Guan H, et al. Long-term diosbulbin B treatment induced liver fibrosis in mice. Chem Biol Interact. 2019;298:15–23.
   PubMed Web of Science ®Google Scholar
• Ji H, Song N, Ren J, et al. Systems toxicology approaches reveal the mechanisms of hepatotoxicity induced by diosbulbin b in male mice. Chem Res Toxicol. 2020;33(6): p. 1389–1402.
   PubMed Web of Science ®Google Scholar
• Li H, Peng Y, Zheng J. Dioscorea bulbifera L.-induced hepatotoxicity and involvement of metabolic activation of furanoterpenoids. Drug Metab Rev. 2020;52(4): p. 568–584.
   PubMed Web of Science ®Google Scholar
• Gu P, Wusiman A, Wang S, et al. Polyethylenimine-coated PLGA nanoparticles-encapsulated angelica sinensis polysaccharide as an adjuvant to enhance immune responses. Carbohydr Polym. 2019;223:115128.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cui Z, Mei H, et al. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer. Carbohydr Polym. 2019;219:143–154.
   PubMed Web of Science ®Google Scholar
• Li MM, Zhang Y, Wu J, et al. Polysaccharide from angelica sinensis suppresses inflammation and reverses anemia in complete freund’s adjuvant-induced rats. Curr Med Sci. 2020;40(2): p. 265–274.
   PubMed Web of Science ®Google Scholar
• Qian W, Cai X, Qian Q, et al. Angelica sinensis polysaccharide suppresses epithelial-mesenchymal transition and pulmonary fibrosis via a DANCR/AUF-1/FOXO3 regulatory axis. Aging Dis. 2020;11(1): p. 17–30.
   PubMed Web of Science ®Google Scholar
• Qin L, Chen H, Ding X, et al. Utilizing network pharmacology to explore potential mechanisms of YiSui nongjian formula in treating myelodysplastic syndrome. Bioengineered. 2021;12(1): p.2238–2252.
   PubMed Web of Science ®Google Scholar
• Wang S, Li X, Bao J, et al. Protective potential of angelica sinensis polysaccharide extract against ethylene glycol-induced calcium oxalate urolithiasis. Ren Fail. 2018;40(1): p. 618–627.
   PubMed Web of Science ®Google Scholar
• Chen Z, Cheng L, Zhang J, et al. Angelica sinensis polysaccharide prevents mitochondrial apoptosis by regulating the Treg/Th17 ratio in aplastic anemia. BMC Complement Med Ther. 2020;20(1): p. 192.
   PubMedGoogle Scholar
• Cao P, Sun J, Sullivan MA, et al. Angelica sinensis polysaccharide protects against acetaminophen-induced acute liver injury and cell death by suppressing oxidative stress and hepatic apoptosis in vivo and in vitro. Int J Biol Macromol. 2018;111:1133–1139.
   PubMed Web of Science ®Google Scholar
• Gao Z, Zhang C, Tian W, et al. The antioxidative and hepatoprotective effects comparison of Chinese angelica polysaccharide(CAP)and selenizing CAP (sCAP) in CCl(4) induced hepatic injury mice. Int J Biol Macromol. 2017;97(p):46–54. .
   PubMed Web of Science ®Google Scholar
• Wang K, Wang J, Song M, et al. Angelica sinensis polysaccharide attenuates CCl(4)-induced liver fibrosis via the IL-22/STAT3 pathway. Int J Biol Macromol. 2020;162(p):273–283.
   PubMed Web of Science ®Google Scholar
• Wang K. Autophagy and apoptosis in liver injury. Cell Cycle. 2015;14(11): p. 1631–42.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Hikita H, Tatsumi T, et al. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology. 2016;64(6): p. 1994–2014.
   PubMed Web of Science ®Google Scholar
• Lei Z, Deng M, Yi Z, et al. cGAS-mediated autophagy protects the liver from ischemia-reperfusion injury independently of STING. Am J Physiol Gastrointest Liver Physiol. 2018;314(6): p. G655–g667. .
   PubMed Web of Science ®Google Scholar
• Liu Y, Song A, Wu H, et al. Paeonol inhibits apoptosis of vascular smooth muscle cells via up-regulation of autophagy by activating class III PI3K/Beclin-1 signaling pathway. Life Sci. 2021;264:118714.
   PubMed Web of Science ®Google Scholar
• Zhang C, Huang C, Yang P, et al. Eldecalcitol induces apoptosis and autophagy in human osteosarcoma MG-63 cells by accumulating ROS to suppress the PI3K/Akt/mTOR signaling pathway. Cell Signal. 2021;78:109841.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang W, Pan W, et al. WWOX promotes apoptosis and inhibits autophagy in paclitaxel‑treated ovarian carcinoma cells. Mol Med Rep. 2021;23(1): p. 1.
   Web of Science ®Google Scholar
• Ye J, Xue M, Liu Y, et al. Diosbulbin B-induced mitochondria-dependent apoptosis in l-02 hepatocytes is regulated by reactive oxygen species-mediated autophagy. Front Pharmacol. 2019;10:676.
   PubMed Web of Science ®Google Scholar
• Xu C, Ni S, Zhuang C, et al. Polysaccharide from Angelica sinensis attenuates SNP-induced apoptosis in osteoarthritis chondrocytes by inducing autophagy via the ERK1/2 pathway. Arthritis Res Ther. 2021;23(1): p. 47.
   PubMed Web of Science ®Google Scholar
• Long T, Wang L, Yang Y, et al. Protective effects of trans-2,3,5,4ʹ-tetrahydroxystilbene 2-O-β-d-glucopyranoside on liver fibrosis and renal injury induced by CCl(4)via down-regulating p-ERK1/2 and p-Smad1/2. Food Funct. 2019;10(8): p. 5115–5123.
   PubMed Web of Science ®Google Scholar
• Cai LL, Xu HT, Wang QL, et al. EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition. Int J Mol Med. 2020;45(6): p. 1825–1837.
   PubMed Web of Science ®Google Scholar
• Fu J, Chen X, Liu X, et al. ELABELA ameliorates hypoxic/ischemic-induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K/AKT and ERK1/2 pathways. Stem Cell Res Ther. 2020;11(1): p. 541. .
   PubMed Web of Science ®Google Scholar
• Ning M, Qin S, Tian J, et al. LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway. Bioengineered. 2021;12(1): p. 1543–1554.
   PubMed Web of Science ®Google Scholar
• Wang H, Li H, Chen X, et al. ERK1/2-mediated autophagy is essential for cell survival under Ochratoxin A exposure in IPEC-J2 cells. Toxicol Appl Pharmacol. 2018;360:38–44.
   PubMed Web of Science ®Google Scholar
• Niu C, Wang J, Ji L, et al. Protection of Angelica sinensis (Oliv) Diels against hepatotoxicity induced by Dioscorea bulbifera L. and its mechanism. Biosci Trends. 2014;8(5): p. 253–9.
   PubMed Web of Science ®Google Scholar
• Niu C, Sheng Y, Zhu E, et al. Ferulic acid prevents liver injury induced by diosbulbin B and its mechanism. Biosci Trends. 2016;10(5): p. 386–391.
   PubMed Web of Science ®Google Scholar